A Study of the Drug Isavuconazole to Prevent COVID-19-associated Pulmonary Aspergillosis
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Severe Acute Respiratory Syndrome Coronavirus 2 Aspergillosis Invasive Isavuconazole Antifungal Agents Anti-infective Agents Coronavirus-associated Invasive Pulmonary Aspergillosis CAPA Coronavirus Infections Aspergillosis Severe Acute Respiratory Syndrome COVID-19 Pulmonary Aspergillosis Isavuconazonium Injection [Cresemba]
Lead Scientist at UC Davis
- George Thompson, MD
Associate Professor, Infectious Diseases. Authored (or co-authored) 151 research publications.